New oral migraine drug, Amerge
Glaxo is introducing their new oral migraine drug, Amerge.
Think of Amerge (naratriptan) as similar to oral Imitrex (sumatriptan)...except Amerge is longer-acting.
This means fewer recurrent headaches with Amerge than with Imitrex. About 40% of patients using Imitrex have recurrent headaches because of its short half-life.